Insider Transactions in Q1 2025 at Icu Medical Inc (ICUI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2025
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-21.67%
|
$248,019
$141.97 P/Share
|
|
Mar 08
2025
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,189
+28.2%
|
-
|
|
Mar 08
2025
|
Ben Sousa Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
550
-22.49%
|
$77,550
$141.97 P/Share
|
|
Mar 08
2025
|
Ben Sousa Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
957
+28.12%
|
-
|
|
Mar 08
2025
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-7.05%
|
$134,373
$141.97 P/Share
|
|
Mar 08
2025
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,153
+13.74%
|
-
|
|
Mar 07
2025
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-11.25%
|
$88,125
$141.97 P/Share
|
|
Mar 07
2025
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,073
+16.19%
|
-
|
|
Mar 07
2025
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+2.95%
|
-
|
|
Mar 07
2025
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,775
-1.7%
|
-
|
|
Mar 07
2025
|
Ben Sousa Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
260
-14.87%
|
$36,660
$141.97 P/Share
|
|
Mar 07
2025
|
Ben Sousa Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
430
+19.73%
|
-
|
|
Mar 07
2025
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-3.95%
|
$65,847
$141.97 P/Share
|
|
Mar 07
2025
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
966
+7.55%
|
-
|
|
Mar 07
2025
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,146
+7.34%
|
-
|
|
Mar 07
2025
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,213
-56.52%
|
$171,033
$141.97 P/Share
|
|
Mar 07
2025
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,146
+50.0%
|
-
|
|
Jan 02
2025
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
1,373
-1.3%
|
$212,815
$155.48 P/Share
|
|
Jan 02
2025
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,373
+1.28%
|
$120,824
$88.76 P/Share
|